Molina Healthcare, Inc (NYSE:MOH – Get Free Report) Director Dale Wolf sold 1,600 shares of the stock in a transaction that occurred on Friday, November 13th. The stock was sold at an average price of $206.12, for a total value of $329,792.00. Following the completion of the sale, the director directly owned 14,337 shares of the company’s stock, valued at approximately $2,955,142.44. This trade represents a 10.04% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Molina Healthcare Stock Down 0.2%
Shares of NYSE:MOH traded down $0.48 during mid-day trading on Friday, hitting $209.37. 362,848 shares of the company traded hands, compared to its average volume of 997,807. The stock has a market cap of $10.93 billion, a P/E ratio of -218.09, a P/E/G ratio of 12.38 and a beta of 0.75. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.95. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $244.89. The stock has a 50-day moving average price of $202.56 and a two-hundred day moving average price of $185.69.
Molina Healthcare (NYSE:MOH – Get Free Report) last announced its quarterly earnings results on Wednesday, October 21st. The company reported $0.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.79 by $0.10. The business had revenue of $11.08 billion during the quarter, compared to the consensus estimate of $10.86 billion. Molina Healthcare had a positive return on equity of 2.50% and a negative net margin of 0.11%. Molina Healthcare’s revenue was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.84 earnings per share. On average, equities research analysts forecast that Molina Healthcare, Inc will post 5.30 earnings per share for the current year.
Recent Molina Healthcare Headlines
These are some of the MOH headlines that stood out recently:
- Negative Sentiment: Zacks Research lowered its EPS estimates for Q1 2027 to $2.48 from $2.53, Q3 2027 to $2.17 from $2.23, and Q3 2028 to $3.85 from $4.06. The analyst firm maintained a Hold rating; the downward revisions may weigh on sentiment about Molina’s earnings outlook.
- Negative Sentiment: Three insiders reported selling a combined 10,382 shares for about $2.11 million, reducing their individual holdings by roughly 6% to 12%. These sales may be viewed as a negative signal, though insider transactions alone do not establish a change in the company’s fundamentals. Jeff Barlow SEC filing Richard Schapiro SEC filing Dale Wolf SEC filing
Wall Street Analyst Weigh In
MOH has been the topic of a number of recent analyst reports. Robert W. Baird set a $198.00 price target on shares of Molina Healthcare in a research report on Friday, October 23rd. Jefferies Financial Group restated a “hold” rating and set a $220.00 price target on shares of Molina Healthcare in a report on Friday, October 23rd. Morgan Stanley upped their price objective on shares of Molina Healthcare from $167.00 to $192.00 and gave the stock an “equal weight” rating in a research report on Friday, October 23rd. Sanford C. Bernstein reiterated an “outperform” rating on shares of Molina Healthcare in a research note on Tuesday, October 27th. Finally, Wall Street Zen upgraded shares of Molina Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, October 24th. Three equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $213.88.
Read Our Latest Analysis on Molina Healthcare
Institutional Trading of Molina Healthcare
Large investors have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in Molina Healthcare in the second quarter valued at about $1,503,052,000. Dimensional Fund Advisors LP increased its stake in shares of Molina Healthcare by 23.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,394,882 shares of the company’s stock worth $185,929,000 after purchasing an additional 267,121 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of Molina Healthcare by 11.9% during the 2nd quarter. Wellington Management Group LLP now owns 1,267,207 shares of the company’s stock worth $289,810,000 after purchasing an additional 135,247 shares during the last quarter. Manning & Napier Advisors LLC purchased a new stake in shares of Molina Healthcare during the 2nd quarter worth approximately $152,339,000. Finally, Maverick Capital Ltd. bought a new stake in shares of Molina Healthcare in the 1st quarter worth approximately $86,081,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc. is a managed care company that provides health insurance plans primarily to people covered by government-sponsored programs. Its offerings include Medicaid plans, Medicare plans for eligible individuals and dual-eligible members, and health plans sold through government marketplaces under the Affordable Care Act. The company was founded in 1980 by physician C. David Molina in Long Beach, California, initially serving low-income families through community clinics. It later shifted its focus to providing managed health care, with Medicaid becoming a central part of its business.
Recommended Stories
- Five stocks we like better than Molina Healthcare
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
